1. Field of the Invention
The present invention relates to a method for implanting an ophthalmic implant, and more particularly, to a method for implanting a transcorneal implant through a paracentesis T-incision.
2. Description of the Related Art
Glaucoma, a condition caused by optic nerve cell degeneration, is the second leading cause of preventable blindness in the world today. In the human eye, aqueous humor is a transparent liquid that is constantly secreted by the ciliary body around the lens and flows into the region of the eye between the cornea and the lens, the anterior chamber. The trabecular meshwork provides the means by which the aqueous humor naturally drains from the anterior chamber. A major symptom of glaucoma is a high intraocular pressure, or “IOP,” which is caused by the trabecular meshwork failing to drain enough aqueous humor fluid from within the eye.
Conventional glaucoma therapy has been directed at protecting the optic nerve and preserving visual function by attempting to lower IOP using various methods, such as using drugs or surgery methods, including trabeculectomy and the use of implants. Trabeculectomy is a very invasive surgical procedure in which no device or implant is used. Typically, a surgical procedure is performed to puncture or reshape the trabecular meshwork by surgically creating a channel, thereby opening the sinus venosus.
Another surgical technique typically used involves the use of implants, such as stents or shunts, which are positioned within the eye and are typically relatively large. Such devices are implanted during any number of surgically invasive procedures, and serve to relieve internal eye pressure by permitting aqueous humor fluid to flow from the anterior chamber, through the sclera, and into a conjunctive bleb over the sclera. These procedures are very labor intensive for the surgeons and may be subject to failure due to scarring and cyst formations.
Another problem often related to the treatment of glaucoma with drugs relates to the challenge of delivering drugs to the eye. Current methods of delivering drugs to the eye are not as efficient or effective as desirable. Most drugs for the eye are applied in the form of eye drops, which have to penetrate through the cornea and into the eye. Drops are an inefficient way of delivering drugs; much of the drug never reaches the inside of the eye. Another treatment procedure includes injections. Drugs may be injected into the eye, but this is often traumatic and the eye typically needs to be injected on a regular basis.
One solution to the problems encountered with treatment of glaucoma using drops and injections involves the use of a transcorneal shunt, as disclosed herein. The transcorneal shunt is designed to be an effective means to reduce the intraocular pressure in the eye by shunting aqueous humor fluid from the anterior chamber of the eye. Surgical implantation of a transcorneal shunt is less invasive and quicker than other surgical options because the device is intended for implantation in the clear cornea. The transcorneal shunt drains aqueous humor fluid through the cornea to the tear film, rather than to the trabecular meshwork.
Additional details of ophthalmic shunts can be found, for example, in U.S. patent application Ser. No. 10/857,452, entitled “Ocular Implant and Methods for Making and Using Same,” filed Jun. 1, 2004 and published Jun. 2, 2005 under U.S. Publication No. 2005/0119737 A1, as well as International Patent Application No. PCT/US01/00350, entitled “Systems And Methods For Reducing Intraocular Pressure”, filed on Jan. 5, 2001 and published on Jul. 19, 2001 under the International Publication No. WO 01/50943. Details of ophthalmic shunts can also be found in U.S. Pat. No. 5,807,302, entitled “Treatment of Glaucoma,” filed Apr. 1, 1996 and issued Sep. 15, 1998. The entire contents of these applications and patent are incorporated herein by reference.
Accordingly, it is an aspect of the present invention to provide the ability to implant a shunt through a cornea while minimizing risk of damage to the iris or lens, and providing a substantially leak-free seal around the shunt.
The foregoing and/or other aspects of the present invention are achieved by providing a method for implanting a transcorneal shunt having a cap, a foot, and a body connecting the cap and the foot, the body having a lesser circumference than either the cap or the foot. The method may include: creating a first corneal incision to create a tunnel, such that the a far end of the first incision enters the anterior chamber; and creating a second corneal incision opening a roof of the tunnel to an end point past the far end of the first incision and creating flaps. The method may also include: guiding a shunt to the end point, so that the foot of the shunt is under the flaps; rotating the shunt until the foot is entirely within the anterior chamber; and rotating the shunt back to a neutral position, such that a portion of the foot is beneath a floor of the tunnel.
The foregoing and/or other aspects of the present invention are also achieved by providing a method for creating a corneal paracentesis for implantation of a transcorneal shunt. The method may include: creating a first corneal incision to create a tunnel, such that the a far end of the first incision enters the anterior chamber; and creating a second corneal incision opening a roof of the tunnel to an end point past the far end of the first incision, to define an implantation location for the shunt and complete the paracentesis.
The foregoing and/or other aspects of the present invention are also achieved by providing a corneal paracentesis T-incision, including: a clear corneal incision creating a tunnel from a surface of the clear cornea to the anterior chamber; and a second incision, creating flaps and opening a roof of the clear corneal incision tunnel to an end point past a far end of the clear corneal incision tunnel.
The foregoing and/or other aspects of the present invention are also achieved by providing a corneal implant implanted in a paracentesis T-incision, the paracentesis T-incision including a clear corneal incision creating a tunnel from a surface of the clear cornea to the anterior chamber, and a second incision, creating flaps and opening a roof of the clear corneal incision tunnel to an end point past a far end of the clear corneal incision tunnel. The implant has a body connecting a cap and a foot, the foot is disposed within the anterior chamber, a portion of the foot is disposed beneath a floor of the clear corneal incision tunnel, and the flaps are tucked under the cap.
Additional and/or other aspects and advantages of the present invention will be set forth in part in the description that follows and, in part, will be apparent from the description, or may be learned by practice of the invention.
The above and/or other aspects and advantages of embodiments of the invention will become apparent and more readily appreciated from the following detailed description, taken in conjunction with the accompanying drawings, of which:
Reference will now be made in detail to embodiments of the present invention, examples of which are illustrated in the accompanying drawings, wherein like reference numerals refer to the like elements throughout. The embodiments described explain the present invention by referring to the figures.
If the shunt 30 is made of, for example, hydrogel, these sizes represent final or hydrated dimensions of the shunt 30, since in a dehydrated state, the dimensions would be reduced by about 22%. Other materials that can be used to manufacture ophthalmic shunt 30 include: elastomeric materials, such as silicone rubber and polyurethane; glass; ceramic; polycarbonate; acrylic resin; stainless steel; titanium; silver; gold; and platinum. Materials that can be used to manufacture the filter 42 include: silicon, polymers, or sintered metals, such as titanium.
But since the incision is substantially a straight line, and is larger than a diameter of the foot 34, as shown, e.g., in
Additionally, implantation using this incision technique may not always result in optimal shunt placement.
Further, using the above-described method, during the creation of a perpendicular corneal incision close to the limbus 70, there is a risk that the blade may hit the iris 72 or lens 74 (see
Accordingly, a new method has been developed for implanting a transcorneal shunt via a paracentesis T-incision.
Dr. Howard Fine introduced a clear corneal incision for use in penetrating keratoplasty, or corneal transplantation. Clear corneal incisions have also been employed in cataract surgeries, e.g., phacoemulsification, in which the cataract is emulsified by a vibrating needle, and then aspirated. One of the primary advantages of a clear corneal incision is that sutures are generally not necessary to close the wound.
In
Next, the surgeon rotates the shunt 30 up to about 90°, rotating the cap 32 towards the limbus. According to one embodiment, an axis for this rotation is substantially perpendicular to the second incision. The direction of rotation is represented by the rotational arrows in
Then, the surgeon rotates the shunt 30 back by up to about 90° to a neutral position (illustrated by the rotational arrows of
Following this second rotation, as shown in
Once the shunt 30 is seated, as shown in
After the shunt 30 has been implanted, a suture may be used for placement of the corneal tissue. A substantially leak-free seal around the device, however, will likely be achieved without the use of the suture.
Accordingly, after the tucking of the flaps 82, in accordance with an embodiment of the present invention, a corneal implant (e.g. shunt 30) is implanted in a paracentesis T-incision. The paracentesis T-incision includes a clear corneal incision creating a tunnel from a surface of the clear cornea to the anterior chamber, and a second incision, creating flaps and opening a roof of the clear corneal incision tunnel to an end point past a far end of the clear corneal incision tunnel. The implant has a body connecting a cap and a foot, and the foot is disposed within the anterior chamber. Additionally, a portion of the foot is disposed beneath a floor of the clear corneal incision tunnel, and the flaps are tucked under the cap.
As shown and described herein, the new paracentesis T incision enables a foot of a corneal shunt to be implanted through the cornea without the seating issues and injuries to the iris and/or lens that can occur using previous methods, and the flaps created by unroofing the clear corneal incision cover the wound around the device to create a substantially leak-free seal.
Although a few embodiments of the present invention have been shown and described, the present invention is not limited to the described embodiments. Instead, it would be appreciated by those skilled in the art that changes may be made to these embodiments without departing from the principles and spirit of the invention, the scope of which is defined by the claims and their equivalents.